DE69926616D1 - Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden - Google Patents
Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerdenInfo
- Publication number
- DE69926616D1 DE69926616D1 DE69926616T DE69926616T DE69926616D1 DE 69926616 D1 DE69926616 D1 DE 69926616D1 DE 69926616 T DE69926616 T DE 69926616T DE 69926616 T DE69926616 T DE 69926616T DE 69926616 D1 DE69926616 D1 DE 69926616D1
- Authority
- DE
- Germany
- Prior art keywords
- disorders
- reboxetine
- treatment
- addiction
- neuropsychiatric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8123198P | 1998-04-09 | 1998-04-09 | |
| US81231P | 1998-04-09 | ||
| PCT/US1999/004289 WO1999052531A1 (en) | 1998-04-09 | 1999-04-02 | New treatments for nervous disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69926616D1 true DE69926616D1 (de) | 2005-09-15 |
| DE69926616T2 DE69926616T2 (de) | 2006-05-24 |
Family
ID=22162900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69926616T Expired - Fee Related DE69926616T2 (de) | 1998-04-09 | 1999-04-02 | Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6352986B1 (de) |
| EP (1) | EP1069900B1 (de) |
| JP (1) | JP2002511414A (de) |
| KR (1) | KR20010034758A (de) |
| CN (1) | CN1301164A (de) |
| AT (1) | ATE301462T1 (de) |
| AU (1) | AU756373B2 (de) |
| BR (1) | BR9909478A (de) |
| CA (2) | CA2321157A1 (de) |
| CZ (1) | CZ297346B6 (de) |
| DE (1) | DE69926616T2 (de) |
| DK (1) | DK1069900T3 (de) |
| EA (1) | EA200001049A1 (de) |
| ES (1) | ES2244189T3 (de) |
| HU (1) | HUP0102436A3 (de) |
| IL (1) | IL138855A0 (de) |
| NO (1) | NO20005059D0 (de) |
| NZ (1) | NZ507398A (de) |
| PL (1) | PL193797B1 (de) |
| PT (1) | PT1069900E (de) |
| SK (1) | SK14492000A3 (de) |
| TR (1) | TR200002868T2 (de) |
| WO (1) | WO1999052531A1 (de) |
| ZA (1) | ZA200004454B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586427B2 (en) * | 1998-04-09 | 2003-07-01 | Pharmacia & Upjohn Company | Treatments for nervous disorders |
| PT1459750E (pt) | 1999-07-01 | 2005-08-31 | Pharmacia & Upjohn Co Llc | (s,s)- reboxetina para tratar a fibromialgia ou outras perturbacoes somatoformes |
| EP1500396B1 (de) * | 1999-07-01 | 2005-09-28 | Pharmacia & Upjohn Company LLC | Reboxetin zur Behandlung von Migränekopfschmerzen |
| KR20020081403A (ko) * | 2000-03-07 | 2002-10-26 | 일라이 릴리 앤드 캄파니 | 건선의 치료 |
| SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| US20040102440A1 (en) * | 2002-07-01 | 2004-05-27 | Wong Erik Ho Fong | Method of promoting smoking cessation |
| PT1578422E (pt) | 2002-12-20 | 2007-06-14 | Niconovum Ab | Material particulado contendo nicotina fisicamente e quimicamente estável |
| KR101594898B1 (ko) | 2005-07-15 | 2016-02-18 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도 |
| JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ | 改善された嗅ぎたばこ組成物 |
| US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
| EA020553B1 (ru) | 2009-05-12 | 2014-12-30 | Олбани Молекьюлар Рисерч, Инк. | 7-([1,2,4]ТРИАЗОЛО[1,5-α]ПИРИДИН-6-ИЛ)-4-(3,4-ДИХЛОРФЕНИЛ)-1,2,3,4-ТЕТРАГИДРОИЗОХИНОЛИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИЧЕСКИХ РАССТРОЙСТВ |
| JP5739415B2 (ja) | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | （Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用 |
| US9045468B2 (en) | 2010-08-17 | 2015-06-02 | Albany Molecular Research, Inc. | 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
| DE3275000D1 (en) * | 1981-08-07 | 1987-02-12 | Holset Engineering Co | Impeller for centrifugal compressor |
| GB8419683D0 (en) | 1984-08-02 | 1984-09-05 | Erba Farmitalia | 3-substituted derivatives of 1-amino-2-hydroxy-propane |
| US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
| ZA958725B (en) * | 1994-10-20 | 1997-04-16 | Lilly Co Eli | Treatment of disorders with duloxetine |
| US5658590A (en) * | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
| NZ313076A (en) * | 1995-07-24 | 1999-11-29 | Lilly Co Eli | Medicament containing duloxetine for treating hyperactivity and attention deficiency disorders |
| AU9214498A (en) * | 1997-09-23 | 1999-04-12 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
| UA56257C2 (uk) | 1997-09-23 | 2003-05-15 | Елі Ліллі Енд Компані | Спосіб лікування неадекватної визивної поведінки |
-
1999
- 1999-04-02 JP JP2000543141A patent/JP2002511414A/ja not_active Withdrawn
- 1999-04-02 BR BR9909478-9A patent/BR9909478A/pt not_active Application Discontinuation
- 1999-04-02 EA EA200001049A patent/EA200001049A1/ru unknown
- 1999-04-02 PL PL99346293A patent/PL193797B1/pl unknown
- 1999-04-02 HU HU0102436A patent/HUP0102436A3/hu unknown
- 1999-04-02 KR KR1020007011158A patent/KR20010034758A/ko not_active Application Discontinuation
- 1999-04-02 TR TR2000/02868T patent/TR200002868T2/xx unknown
- 1999-04-02 DE DE69926616T patent/DE69926616T2/de not_active Expired - Fee Related
- 1999-04-02 EP EP99916114A patent/EP1069900B1/de not_active Expired - Lifetime
- 1999-04-02 CZ CZ20003671A patent/CZ297346B6/cs not_active IP Right Cessation
- 1999-04-02 AT AT99916114T patent/ATE301462T1/de not_active IP Right Cessation
- 1999-04-02 CA CA002321157A patent/CA2321157A1/en not_active Abandoned
- 1999-04-02 CN CN99804011A patent/CN1301164A/zh active Pending
- 1999-04-02 CA CA002634698A patent/CA2634698A1/en not_active Abandoned
- 1999-04-02 DK DK99916114T patent/DK1069900T3/da active
- 1999-04-02 SK SK1449-2000A patent/SK14492000A3/sk unknown
- 1999-04-02 ES ES99916114T patent/ES2244189T3/es not_active Expired - Lifetime
- 1999-04-02 NZ NZ507398A patent/NZ507398A/en unknown
- 1999-04-02 IL IL13885599A patent/IL138855A0/xx unknown
- 1999-04-02 WO PCT/US1999/004289 patent/WO1999052531A1/en active IP Right Grant
- 1999-04-02 PT PT99916114T patent/PT1069900E/pt unknown
- 1999-04-02 AU AU34494/99A patent/AU756373B2/en not_active Ceased
-
2000
- 2000-05-05 US US09/565,780 patent/US6352986B1/en not_active Expired - Fee Related
- 2000-08-28 ZA ZA200004454A patent/ZA200004454B/en unknown
- 2000-10-06 NO NO20005059A patent/NO20005059D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20003671A3 (en) | 2001-06-13 |
| DE69926616T2 (de) | 2006-05-24 |
| CZ297346B6 (cs) | 2006-11-15 |
| ES2244189T3 (es) | 2005-12-01 |
| JP2002511414A (ja) | 2002-04-16 |
| HUP0102436A2 (hu) | 2001-11-28 |
| CA2634698A1 (en) | 1999-10-21 |
| ZA200004454B (en) | 2002-04-24 |
| ATE301462T1 (de) | 2005-08-15 |
| IL138855A0 (en) | 2001-10-31 |
| WO1999052531A1 (en) | 1999-10-21 |
| KR20010034758A (ko) | 2001-04-25 |
| PL193797B1 (pl) | 2007-03-30 |
| EP1069900A1 (de) | 2001-01-24 |
| HUP0102436A3 (en) | 2002-01-28 |
| DK1069900T3 (da) | 2005-10-31 |
| BR9909478A (pt) | 2000-12-19 |
| NZ507398A (en) | 2004-01-30 |
| EP1069900B1 (de) | 2005-08-10 |
| AU756373B2 (en) | 2003-01-09 |
| PL346293A1 (en) | 2002-01-28 |
| SK14492000A3 (sk) | 2001-06-11 |
| US6352986B1 (en) | 2002-03-05 |
| CN1301164A (zh) | 2001-06-27 |
| CA2321157A1 (en) | 1999-10-21 |
| PT1069900E (pt) | 2005-10-31 |
| NO20005059L (no) | 2000-10-06 |
| EA200001049A1 (ru) | 2001-04-23 |
| TR200002868T2 (tr) | 2001-01-22 |
| AU3449499A (en) | 1999-11-01 |
| NO20005059D0 (no) | 2000-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY127739A (en) | Use of pramipexole for the treatment of addictive disorders | |
| DE69926616D1 (de) | Verwendung von reboxetine zur behandlung neuropsychiatrischer beschwerden | |
| YU71901A (sh) | NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA | |
| BR0205722A (pt) | Formulação de liberação prolongada e método para o tratamento de um paciente que sofre de dor | |
| TW329387B (en) | Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| RU94040387A (ru) | Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| DK0796103T3 (da) | Anvendelse af røgelse til behandling af Alzheimer-sygdommen | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DK1202727T3 (da) | Anvendelse af agonister af GABAB-receptorer og farmaceutisk acceptable derivater deraf til behandling for at opnå fortsat nikotinafholdenhed hos nikotinafhængige patienter | |
| ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
| BR9506748A (pt) | Compostos preparação farmacêutica utilização de um composto e processos para o tratamento de um indivíduo sofrendo de dor e para a preparação de um composto | |
| BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
| EA200300271A1 (ru) | Соединения для лечения расстройств, связанных с зависимостью | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| DE60121978D1 (de) | 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN | |
| DE60122764D1 (de) | Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen | |
| DE69910242D1 (de) | Verwendung eines Nikotin-Rezeptor Agonisten zur Herstellung eines Medikaments zur Behandlung von Zwangsneurosen | |
| DE69806248D1 (de) | Pharmazeutische zubereitung zur behandlung sogenannter rastloser beine | |
| ATE286728T1 (de) | Verwendung von homocysteinderivaten zur behandlung von bakteriellen infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |